JP2020105169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020105169A5 JP2020105169A5 JP2019227342A JP2019227342A JP2020105169A5 JP 2020105169 A5 JP2020105169 A5 JP 2020105169A5 JP 2019227342 A JP2019227342 A JP 2019227342A JP 2019227342 A JP2019227342 A JP 2019227342A JP 2020105169 A5 JP2020105169 A5 JP 2020105169A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- lysosomal enzyme
- expression vector
- vlp
- lysosomal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WOPCT/EP2018/085699 | 2018-12-18 | ||
| PCT/EP2018/085699 WO2020125962A1 (en) | 2018-12-18 | 2018-12-18 | A novel drug delivery system and methods providing thereof |
| PCT/EP2019/060814 WO2020126116A1 (en) | 2018-12-18 | 2019-04-26 | Vlp for the treatment of a lysosomal storage disease |
| WOPCT/EP2019/060814 | 2019-04-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020105169A JP2020105169A (ja) | 2020-07-09 |
| JP2020105169A5 true JP2020105169A5 (https=) | 2022-12-26 |
Family
ID=65009711
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538254A Expired - Fee Related JP6884432B2 (ja) | 2018-12-18 | 2018-12-18 | 新規薬物送達システムおよびそれを提供する方法 |
| JP2019227342A Pending JP2020105169A (ja) | 2018-12-18 | 2019-12-17 | リソソーム蓄積症の処置のためのｖｌｐ |
| JP2022521659A Pending JP2022551531A (ja) | 2018-12-18 | 2020-10-13 | Ｊｏｈｎ ＣｕｎｎｉｎｇｈａｍウイルスＶＬＰを提供するための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538254A Expired - Fee Related JP6884432B2 (ja) | 2018-12-18 | 2018-12-18 | 新規薬物送達システムおよびそれを提供する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521659A Pending JP2022551531A (ja) | 2018-12-18 | 2020-10-13 | Ｊｏｈｎ ＣｕｎｎｉｎｇｈａｍウイルスＶＬＰを提供するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US11279938B2 (https=) |
| EP (2) | EP3688147B8 (https=) |
| JP (3) | JP6884432B2 (https=) |
| CN (3) | CN111587289B (https=) |
| BR (3) | BR112019014209A2 (https=) |
| CA (3) | CA3049197C (https=) |
| DK (1) | DK3688147T3 (https=) |
| ES (1) | ES2933275T3 (https=) |
| HU (1) | HUE060952T2 (https=) |
| PL (1) | PL3688147T3 (https=) |
| SI (1) | SI3688147T1 (https=) |
| WO (4) | WO2020125962A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023526528A (ja) * | 2020-05-22 | 2023-06-21 | ノイウェイ ファルマ ゲーエムベーハー | 白質ジストロフィーの処置のためのｖｌｐ |
| WO2022227287A1 (zh) * | 2021-04-25 | 2022-11-03 | 中南大学 | Dnj及其衍生物在制备预防和/或治疗肺动脉高压药物中的应用 |
| CN115448980A (zh) * | 2021-06-08 | 2022-12-09 | 戴德森医疗财团法人嘉义基督教医院 | 表面链结标靶多肽的类病毒颗粒及其用途 |
| EP4166672A1 (en) | 2021-10-15 | 2023-04-19 | NEUWAY Pharma GmbH | A novel method for purification of protein- or peptide-based capsules |
| CN116554279A (zh) * | 2022-01-28 | 2023-08-08 | 思凯生科有限公司 | 包含有专一性表达于前列腺细胞的表达质粒的类病毒颗粒及其用途 |
| WO2024079361A1 (en) | 2022-10-14 | 2024-04-18 | Neuway Pharma Gmbh | A PROTEIN- OR PEPTIDE-BASED CAPSULE (PPC), PREFERABLY A VLP, LOADED WITH A MESSENGER RNA (mRNA) AND A METHOD OF PRODUCTION AND PURIFICATION THEREOF |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19543553B4 (de) | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
| AU2003222568B2 (en) | 2002-01-11 | 2009-05-07 | Bioasis Technologies, Inc. | Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| US7442372B2 (en) | 2003-08-29 | 2008-10-28 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
| FR2920158B1 (fr) | 2007-08-24 | 2010-03-12 | Centre Nat Rech Scient | Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques |
| EP2554664A1 (de) | 2011-08-02 | 2013-02-06 | Life Science Inkubator | Verfahren zur Aufreinigung von Virus-ähnlichen Partikeln (VLP) |
| EP2636746A1 (en) | 2012-03-06 | 2013-09-11 | Life Science Inkubator | A novel drug delivery system based on JCV-VLP |
| AR100419A1 (es) * | 2014-05-14 | 2016-10-05 | Esteve Labor Dr | Vectores de virus adenoasociados para el tratamiento de trastornos de almacenamiento lisosómico |
-
2018
- 2018-12-18 ES ES18830794T patent/ES2933275T3/es active Active
- 2018-12-18 SI SI201830824T patent/SI3688147T1/sl unknown
- 2018-12-18 HU HUE18830794A patent/HUE060952T2/hu unknown
- 2018-12-18 CN CN201880006448.0A patent/CN111587289B/zh not_active Expired - Fee Related
- 2018-12-18 WO PCT/EP2018/085699 patent/WO2020125962A1/en not_active Ceased
- 2018-12-18 PL PL18830794.6T patent/PL3688147T3/pl unknown
- 2018-12-18 US US16/476,724 patent/US11279938B2/en not_active Expired - Fee Related
- 2018-12-18 EP EP18830794.6A patent/EP3688147B8/en active Active
- 2018-12-18 DK DK18830794.6T patent/DK3688147T3/da active
- 2018-12-18 JP JP2019538254A patent/JP6884432B2/ja not_active Expired - Fee Related
- 2018-12-18 BR BR112019014209-6A patent/BR112019014209A2/pt not_active Application Discontinuation
- 2018-12-18 CA CA3049197A patent/CA3049197C/en active Active
-
2019
- 2019-04-26 WO PCT/EP2019/060814 patent/WO2020126116A1/en not_active Ceased
- 2019-10-14 CA CA3121689A patent/CA3121689A1/en active Pending
- 2019-10-14 US US17/311,480 patent/US20230157972A1/en not_active Abandoned
- 2019-10-14 WO PCT/EP2019/077807 patent/WO2020126151A1/en not_active Ceased
- 2019-10-14 BR BR112021010758-4A patent/BR112021010758A2/pt not_active IP Right Cessation
- 2019-12-16 BR BR102019026837-9A patent/BR102019026837A2/pt not_active IP Right Cessation
- 2019-12-16 CA CA3065548A patent/CA3065548A1/en active Pending
- 2019-12-17 JP JP2019227342A patent/JP2020105169A/ja active Pending
- 2019-12-17 CN CN201911300544.9A patent/CN111333702A/zh active Pending
- 2019-12-17 US US16/717,033 patent/US20200224205A1/en not_active Abandoned
-
2020
- 2020-10-13 WO PCT/EP2020/078733 patent/WO2021074123A1/en not_active Ceased
- 2020-10-13 CN CN202080081855.5A patent/CN115135757A/zh active Pending
- 2020-10-13 EP EP20789150.8A patent/EP4045638A1/en not_active Withdrawn
- 2020-10-13 JP JP2022521659A patent/JP2022551531A/ja active Pending
-
2022
- 2022-11-07 US US18/053,198 patent/US20230159938A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020105169A5 (https=) | ||
| JP7066635B2 (ja) | 調節性ポリヌクレオチド | |
| JP2025111747A5 (https=) | ||
| RU2018120736A (ru) | Нацеливающие пептиды для направленной доставки аденоассоциированных вирусов (aav) | |
| RU2018142768A (ru) | Варианты капсидов аденоассоциированного вируса и способы их применения | |
| JP2019506141A5 (https=) | ||
| JP2010512795A5 (https=) | ||
| JP2014509197A (ja) | 標的性治療人腫瘍治療の腫瘍溶解性アデノウイルス及びその応用 | |
| CN117568313B (zh) | 基因编辑组合物及其用途 | |
| JPH09510621A (ja) | 塩基性繊維芽細胞増殖因子（ｂＦＧＦ）をコードする組換えアデノウイルス | |
| JP2018533970A5 (https=) | ||
| CA3186872A1 (en) | Baculovirus expression systems | |
| WO2021042944A1 (zh) | 肌肉靶向的微环dna基因治疗 | |
| JP2022166146A (ja) | フリードライヒ運動失調症の治療用のベクター | |
| CN101586096A (zh) | 一种共表达人源谷氨酸脱羧酶和细胞因子的重组病毒 | |
| JPWO2019209914A5 (https=) | ||
| Patil et al. | Gene therapy: A comprehensive review | |
| Kanzawa et al. | Current and future gene therapy for malignant gliomas | |
| CN120098092A (zh) | 一种aav2变体及其应用 | |
| CN100435848C (zh) | 提高饲料效率和家畜生长速度的基因处理 | |
| JP2009507474A5 (https=) | ||
| JP2014512369A5 (https=) | ||
| ZA202304877B (en) | Recombinant adeno-associated viruses with enhanced liver tropism and uses thereof | |
| CN1909923B (zh) | 基于减毒的兔粘液瘤病毒的单副免疫诱导物 | |
| CN111100847A (zh) | 安全性更高的端粒基因治疗产品使人体健康逆转衰老 |